Close THC-COOH Agreement Did Not Validate a Parent-THC Conversion Between Blood Matrices

THC-COOH agreed more closely between dried capillary spots and venous blood than parent THC did. Good agreement for the metabolite did not establish interchangeability for the psychoactive parent compound.

The analytes had different ratio distributions

The study reported a median dried-spot-to-venous ratio of 1.09 for THC-COOH, with a range of 0.60–1.64. Parent THC had a much wider range, including extreme observations. The comparison therefore depended on which chemical was being measured, despite specimens coming from the same general collection exercise.

A metabolite can answer another exposure question

THC-COOH is an inactive metabolite. Its agreement across these specimen types concerns analytical comparability, not whether it reproduces parent THC concentrations or current drug effects. A narrow metabolite ratio cannot repair an uncertain parent measurement by assumption.

Validate the requested analyte directly

For a proposed matrix substitution, ask whether the relevant compound was evaluated under comparable collection and processing conditions. Do not extend a successful metabolite comparison to every cannabinoid in a panel. The results also came from recreational users sampled without a standardized interval after last use. They were not a controlled impairment study or a validated way to reconstruct a person’s functional state from a metabolite result.

Related analysis: the study’s broader findings and limitations.

Research cited

Bantle and colleagues (2026). Determination of THC and THC-COOH in Dried Capillary Blood Spots and Comparison to Venous Blood of Recreational Cannabis Consumers in a Pilot Study.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Carryover Testing Challenged the Analytical Sequence, Not the Newborn’s Exposure History

The neonatal assay’s carryover assessment examined whether a preceding high-concentration sample could affect a later measurement. It addressed an instrument-process question, not a biological exposure pathway. The protocol deliberately stressed the sequence The investigators used samples at twice the upper quantification limit followed by low-range samples. They considered contamination associated…

Spread the love

Read Article: Carryover Testing Challenged the Analytical Sequence, Not the Newborn’s Exposure History

The Paired Cord-and-Meconium Study Was Not a Survey of All Births

The forty-six specimen pairs came from archived cases in which both tests had been clinically ordered. Their cannabinoid-positive proportions were not population prevalence estimates. Selection followed the availability of paired orders Investigators sought residual meconium and cord tissue from the same newborn where testing for both matrices had been requested….

Spread the love

Read Article: The Paired Cord-and-Meconium Study Was Not a Survey of All Births

A Half-LLOQ Check Was Not the Same as Independently Determining Every Detection Limit

The neonatal cannabinoid study explicitly stated that each analyte’s detection limit was not specifically determined. It checked performance at half the lower quantification limit instead. The validation described what was actually tested The researchers verified relevant acceptance criteria and a signal-to-noise ratio of at least three at concentrations equivalent to…

Spread the love

Read Article: A Half-LLOQ Check Was Not the Same as Independently Determining Every Detection Limit

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us